Estrella Immunopharma, Inc.ESLANASDAQ
LOADING
|||
Cash Flow Under Pressure
Trending higher, below historical average, strong compound growth.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$-7.64M
↓ 42% below average
Average (4y)
$-5.37M
Historical baseline
Range
High:$-670820.00
Low:$-16.07M
CAGR
+83.7%
Consistent expansion
| Period | Value | Change |
|---|---|---|
| 2024 | $-7.64M | +52.5% |
| 2023 | $-16.07M | -1439.3% |
| 2022 | $-1.04M | +27.6% |
| 2021 | $-1.44M | -115.0% |
| 2020 | $-670820.00 | - |